Deserpidine
Generic Name: deserpidine
Manufactured by ABBVIE. Dosage form: TABLET. Route: ORAL. Active ingredients: DESERPIDINE (0.25MG); HYDROCHLOROTHIAZIDE (25MG). Application: NDA012148.
Overview
Manufactured by ABBVIE. Dosage form: TABLET. Route: ORAL. Active ingredients: DESERPIDINE (0.25MG); HYDROCHLOROTHIAZIDE (25MG). Application: NDA012148.
Dosage
Available as tablet for oral use.
Related Medications
Atx-304
atx-304
Dosage form: POWDER. Active ingredients: O-304 (100 g/100g). Category: BULK INGREDIENT.
Recombinant Human Insulin
recombinant human insulin
Dosage form: POWDER. Active ingredients: INSULIN HUMAN (1 g/g). Category: BULK INGREDIENT.
Nemolizumab-ilto
nemolizumab-ilto
Interleukin-31 Receptor alpha Antagonist [EPC]
11 DESCRIPTION Nemolizumab-ilto, an interleukin-31 receptor alpha (IL-31RA) antagonist, is a humanized monoclonal modified immunoglobulin G (IgG) antibody with a molecular weight of approximately 144 kDa. Nemolizumab-ilto is produced by recombinant DNA technology in Chinese Hamster Ovary cells. NEMLUVIO (nemolizumab-ilto) for injection is a sterile, preservative-free, white lyophilized powder in a dualchamber, single-dose, prefilled pen for subcutaneous use.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.